Most Read Articles
Pearl Toh, 6 days ago
A study finds no evidence that using pharmaceutical aids alone for smoking cessation helps improve the chances of successful quitting despite promising results in previous randomized trials and routine prescription of such drugs to help quit smoking.
Elvira Manzano, 3 days ago
Cancer patients at risk for recurrent venous thromboembolism (VTE) are less likely to experience recurrence with rivaroxaban compared with dalteparin, the Select-D trial has shown, ushering in a new standard of care (SoC) for cancer-related VTE.
2 days ago
Weight loss medications that have received the Food and Drug Administration (FDA) approval appear to confer only modest positive benefits for cardiometabolic risk profile, according to a study.
3 days ago
The risk of stroke and subsequent mortality is significantly elevated in patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD), a recent study has shown.

Autistic traits, drive to systemize common in autism, borderline personality disorder

13 Sep 2017
Parent of autistic kids need to reach out for support

Both autism spectrum condition (ASC) and borderline personality disorder (BPD) patients manifest autistic traits and drive to systemize, a new study has shown.

The study involved 624 ASC and 23 BPD patients; an additional 16 patients with both ASC and BPD were also recruited. All participants were made to accomplish the Autism Spectrum Quotient (AQ), Empathy Quotient (EQ) and Systemizing Quotient-Revised (SQ-R) questionnaires. There were 2,081 neurotypical controls (NC).

According to analysis of variance (ANOVA), AQ scores were significantly different among all four groups, (p<0.001), with NCs having the lowest, followed by the BPD, ASC and ASC+BPD groups. The difference in scores between NCs and BPD reached statistical significance, while the scores between BPD and ASC were only marginally different (p=0.047).

Scores in patients with ASC and BPD were significantly higher than those with ASC (p=0.001).

ANOVA also showed that EQ scores were significantly different among all groups (p<0.001), with both NC and BPD patients scoring significantly higher than either ASC or ASC+BPD patients (p<0.001 for all). EQ scores were comparable between NC and BPD patients, and between ASC and ASC+BPD patients.

In terms of SQ-R, both BPD (p=0.016) and ASC (p<0.001) patients scored significantly higher than NCs. ANOVA also found that scores were normally distributed and were significantly different among the groups (p<0.001). In posthoc analyses, the ASC+BPD group did not show significantly different scores compared with any other group.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Pearl Toh, 6 days ago
A study finds no evidence that using pharmaceutical aids alone for smoking cessation helps improve the chances of successful quitting despite promising results in previous randomized trials and routine prescription of such drugs to help quit smoking.
Elvira Manzano, 3 days ago
Cancer patients at risk for recurrent venous thromboembolism (VTE) are less likely to experience recurrence with rivaroxaban compared with dalteparin, the Select-D trial has shown, ushering in a new standard of care (SoC) for cancer-related VTE.
2 days ago
Weight loss medications that have received the Food and Drug Administration (FDA) approval appear to confer only modest positive benefits for cardiometabolic risk profile, according to a study.
3 days ago
The risk of stroke and subsequent mortality is significantly elevated in patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD), a recent study has shown.